HOOKIPA Pharma Inc. (HOOK)
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
HOOKIPA Pharma Inc.
OTC:HOOKHealthcare · Biotechnology
Mkt Cap$14.4M
Float12.15M
O/S12.52M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$9.7M
Net Income-$13.84M
Total Assets$41.86M
Free Cash Flow-$11.52M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$135K
Total Equity$32.52M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:10Reverse splitJul 10, 202410 shares → 1
Balance Sheet Details
Assets$41.86M
Liabilities$9.34M
Accounts Receivable$2.22M
Accounts Payable$810K
Inventory$0
PP&E (Net)$126K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $9.7M | $43.95M | $20.13M | $14.25M | $18.45M | $19.58M | $11.94M | $7.63M | $0 |
| YoY Growth | -77.9% | 118.3% | 41.3% | -22.8% | -5.8% | 64.0% | 56.5% | - | - |
| Cost of Revenue | $682K | $2.75M | $3.55M | $3.6M | $4.64M | $53.13M | $46.31M | $21.96M | $398K |
| Gross Profit | $9.02M | $41.19M | $16.58M | $10.65M | $13.81M | -$33.55M | -$34.37M | -$14.34M | -$398K |
| Gross Margin | 93.0% | 93.7% | 82.4% | 74.7% | 74.8% | -171.3% | -287.8% | -187.9% | - |
| Research and Development | $25.84M | $68.51M | $86.42M | $68.64M | $82.85M | $54.79M | $46.31M | $21.96M | $9.77M |
| Selling, General, and Administrative | $19.75M | $20.23M | $18.63M | $18.76M | $19.18M | $19.74M | $16.71M | $6.84M | $4.38M |
| Other | $0 | -$60.47M | $12.77M | -$3.6M | -$6.55M | -$54.79M | $0 | $133K | -$25K |
| Total Operating Expenses | $45.59M | $28.27M | $117.82M | $83.8M | $95.48M | $19.74M | $63.03M | $23.2M | $12.09M |
| Operating Income (EBIT) | -$36.57M | -$51.45M | -$97.69M | -$73.16M | -$81.67M | -$53.28M | -$51.09M | -$21.18M | -$14.16M |
| Operating Margin | -377.0% | -117.1% | -485.3% | -513.4% | -442.7% | -272.1% | -427.8% | -277.6% | - |
| Interest Expense | $0 | $2K | $317K | $687K | $898K | $786K | $877K | $778K | $606K |
| Interest Income | $840K | $3.7M | $5.29M | $1.63M | $27K | $400K | $1.59M | $0 | $0 |
| Other Income (Expense) | $22.74M | $7.85M | $16.48M | $8.47M | $6.01M | $9.2M | $8.05M | $4.97M | $1.44M |
| Income Before Tax (EBT) | -$13.84M | -$43.61M | -$81.21M | -$64.92M | -$75.67M | -$44.08M | -$43.04M | -$16.21M | -$12.72M |
| Income Tax Expense | $1K | -$106K | $368K | $0 | $0 | $0 | $0 | $24K | $4K |
| Net Income | -$13.84M | -$43.5M | -$81.58M | -$64.92M | -$75.67M | -$44.08M | -$43.04M | -$16.24M | -$12.72M |
| Net Income Margin | -142.6% | -99.0% | -405.3% | -455.6% | -410.2% | -225.1% | -360.4% | -212.8% | - |
| Supplementary Data | |||||||||
| EPS | -1.09 | -3.47 | -8.63 | -9.91 | -23.04 | -16.93 | -24.10 | -177.58 | -139.54 |
| Diluted EPS | -1.09 | -3.47 | -8.63 | -9.91 | -23.04 | -16.93 | -24.10 | -177.57 | -139.54 |
| Weighted Average OS | 12.65M | 12.54M | 9.45M | 6.55M | 3.28M | 2.60M | 1.79M | 91,437 | 91,177 |
| EBITDA | -$35.89M | -$40.85M | -$77.34M | -$60.4M | -$70.13M | -$39.15M | -$39.09M | -$14.79M | -$13.76M |
| EBITDA Margin | -370.0% | -93.0% | -384.2% | -423.9% | -380.1% | -199.9% | -327.4% | -193.9% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $37.42M | $39.68M | $117.1M | $113.44M | $65.92M | $143.18M | $113.15M | $48.58M | $61.36M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $37.42M | $39.68M | $117.1M | $113.44M | $65.92M | $143.18M | $113.15M | $48.58M | $61.36M |
| Accounts Receivable | $2.22M | $23.67M | $19.27M | $22.01M | $21.17M | $20.66M | $9.73M | $7.25M | $6.52M |
| Inventory | $0 | $0 | $0 | -$419K | -$14.27M | -$434K | -$8.19M | $0 | $0 |
| Other Current Assets | $2.08M | $17.31M | $10.75M | $12.16M | $14.84M | $0 | $8.19M | $2.33M | $0 |
| Total Current Assets | $41.73M | $80.67M | $147.12M | $147.2M | $102.14M | $171.5M | $128.02M | $62.31M | $69.96M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $126K | $1.06M | $13.21M | $21.98M | $22.11M | $13.97M | $14.6M | $4.34M | $3.58M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $104K | $425K | $419K | $425K | $434K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $7K | $712K | $581K | $863K | $1.37M | $1.91M | $1.13M | $1.6M | $199K |
| Total Long-Term Assets | $133K | $1.88M | $14.22M | $23.26M | $23.91M | $16.31M | $15.73M | $5.94M | $3.77M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $41.86M | $82.55M | $161.34M | $170.45M | $126.05M | $187.82M | $143.75M | $68.25M | $73.73M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $810K | $8.69M | $12.5M | $5.49M | $8.76M | $8.01M | $944K | $3.66M | $1.48M |
| Short-Term Debt | $135K | $0 | $1.12M | $1.59M | $2.79M | $0 | $1.22M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $367K | $230K | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $4.76M | $14.68M | $15.98M | $6.23M | $4.63M | $3.59M | $7.45M | $725K |
| Other Current Liabilities | $496K | $6.46M | $6.02M | $6.17M | $3.41M | $1.97M | $4.38M | $2.18M | $764K |
| Total Current Liabilities | $6.58M | $24.65M | $41.99M | $35.63M | $27.65M | $21.14M | $14.76M | $14.7M | $4.04M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $0 | $0 | $911K | $2.22M | $4.54M | $3.5M | $4.39M | $3.74M |
| Long-Term Unearned Revenue | $0 | $725K | $19.67M | $25.66M | $21K | $784K | $72K | $1.66M | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $2.76M | $5.63M | $6.02M | $3.42M | $2.65M | $1.15M | $2.23M | $3.1M | $108.61M |
| Total Long-Term Liabilities | $2.76M | $6.68M | $29.49M | $32.3M | $8.8M | $10.55M | $11.09M | $9.16M | $112.35M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $9.34M | $31.33M | $71.48M | $67.94M | $36.45M | $31.69M | $25.85M | $23.85M | $116.39M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $104.77M | $104.77M |
| Common Stock | $2K | $1K | $10K | $5K | $3K | $3K | $3K | $2K | $0 |
| Retained Earnings | -$426.6M | -$412.76M | -$369.26M | -$287.68M | -$222.77M | -$147.1M | -$103.02M | -$59.98M | -$43.74M |
| Comprehensive Income & Other | -$9.7M | -$5.09M | -$7.93M | -$7.16M | -$4.78M | -$6.07M | -$4.65M | -$3.72M | -$1.36M |
| Other Stockholders' Equity | $459.12M | $463.98M | $459.11M | $390.19M | $312.36M | $303.22M | $220.91M | $104.38M | $1.09M |
| Total Equity | $32.52M | $51.21M | $89.86M | $102.52M | $89.59M | $156.12M | $117.9M | $44.4M | -$42.66M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $41.86M | $82.55M | $161.34M | $170.45M | $126.05M | $187.82M | $143.75M | $68.25M | $73.73M |
| Supplementary Data | |||||||||
| Total Debt | $135K | $875K | $6.56M | $6.5M | $10.63M | $10.77M | $11.98M | $4.39M | $3.74M |
| Net Debt | -$37.29M | -$38.81M | -$110.54M | -$106.94M | -$56.29M | -$132.41M | -$101.17M | -$44.19M | -$57.62M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$13.84M | -$43.5M | -$81.58M | -$64.92M | -$75.67M | -$44.08M | -$43.04M | -$16.24M | -$12.72M |
| Depreciation & Amortization | $682K | $2.75M | $3.55M | $3.6M | $4.64M | $4.15M | $3.07M | $640K | $398K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $2.01M | $2.35M | $5.04M | $7.64M | $8.66M | $5.57M | $867K | $770K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $22.1M | -$5.46M | $3.45M | -$2.3M | -$1.94M | -$3.58M | -$3.62M | -$4.99M | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$4.2M | -$11.35M | -$3.52M | -$7.28M | $0 |
| Accounts Payable | -$15.14M | -$1.57M | $6.5M | -$2M | $858K | $6.3M | $4.2M | $3.41M | -$1.17M |
| Other Working Capital | -$1.25M | -$35.21M | -$4.62M | $40.41M | $1.42M | $511K | -$4.44M | $8.59M | $859K |
| Total Working Capital Change | $5.71M | -$42.25M | $5.33M | $36.11M | -$3.86M | -$8.12M | -$7.38M | -$275K | -$313K |
| Other Non-Cash Items | -$4.06M | $4M | $12.83M | $160K | $1.23M | $53K | $52K | $7K | -$45K |
| Net Cash from Operating | -$11.5M | -$76.98M | -$57.52M | -$20M | -$66.02M | -$39.34M | -$41.73M | -$15M | -$11.91M |
| Investing Activities | |||||||||
| Capital Expenditures | -$20K | -$194K | -$4.16M | -$5.02M | -$12.58M | -$2.37M | -$2M | -$2.15M | -$1.3M |
| Acquisitions | $1.83M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $6.81M | -$194K | -$4.16M | -$5.02M | -$12.58M | -$2.37M | -$2M | -$2.15M | -$1.3M |
| Financing Activities | |||||||||
| Debt Repaid | - | $1.14M | $1.75M | $2.85M | $438K | $1.42M | $2.28M | -$425K | -$747K |
| Common Stock Issuance | -$481K | -$135K | $49.04M | $45.69M | $203K | $42.64M | $74.76M | $9K | $58.15M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | -$195K | $0 | $0 | $0 | $6.45M | $58.15M |
| Net Cash from Financing | -$481K | -$1.28M | $65.67M | $72.27M | -$235K | $73.42M | $109.75M | $6.87M | $58.89M |
| Forex Effect | $2.81M | $813K | $90K | -$725K | $2.57M | -$2.11M | -$1.03M | -$2.51M | $2.49M |
| Net Change in Cash | -$2.36M | -$77.64M | $4.08M | $46.53M | -$76.27M | $29.6M | $65M | -$12.78M | $48.18M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$11.5M | -$76.98M | -$57.52M | -$20M | -$66.02M | -$39.34M | -$41.73M | -$15M | -$11.91M |
| Capital Expenditure | -$20K | -$194K | -$4.16M | -$5.02M | -$12.58M | -$2.37M | -$2M | -$2.15M | -$1.3M |
| Free Cash Flow | -$11.52M | -$77.17M | -$61.68M | -$25.01M | -$78.6M | -$41.71M | -$43.73M | -$17.15M | -$13.21M |
| Cash at Beginning | $39.78M | $117.52M | $113.44M | $66.91M | $143.18M | $113.58M | $48.58M | $61.36M | $13.19M |
| Cash at End | $37.42M | $39.89M | $117.52M | $113.44M | $66.91M | $143.18M | $113.58M | $48.58M | $61.36M |